Canget BioTekpharma LLC

We welcome partners from pharmaceutical companies and/or other investors to develop anticancer drugs together with Canget BioTekpharma from its pipeline and share the benefits
Provide genetically engineered cancer cell-based drug screening model systems for other pharmaceutical companies to screen their own compound libraries (US Patent No.: US 7,569,221 B2)

Canget BioTekpharma Company Copyright. All rights reserved.